Cardiac Arrest Treatment Center Differences in Sedation and Analgesia Dosing During Targeted Temperature Management

[1]  F. Espitalier,et al.  A One-Day Prospective National Observational Study on Sedation-Analgesia of Patients with Brain Injury in French Intensive Care Units: The SEDA-BIP-ICU (Sedation-Analgesia in Brain Injury Patient in ICU) Study , 2021, Neurocritical Care.

[2]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. , 2021, Resuscitation.

[3]  Christopher W. Jones,et al.  Association Between Elevated Mean Arterial Blood Pressure and Neurologic Outcome After Resuscitation From Cardiac Arrest: Results From a Multicenter Prospective Cohort Study* , 2019, Critical care medicine.

[4]  A. Rossetti,et al.  Late Awakening in Survivors of Postanoxic Coma: Early Neurophysiologic Predictors and Association With ICU and Long-Term Neurologic Recovery , 2019, Critical care medicine.

[5]  D. Kent,et al.  Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest* , 2018, Critical care medicine.

[6]  J. Chiche,et al.  Comparison of two sedation regimens during targeted temperature management after cardiac arrest. , 2018, Resuscitation.

[7]  M. Wise,et al.  Time to awakening after cardiac arrest and the association with target temperature management. , 2018, Resuscitation.

[8]  M. Kuiper,et al.  Prognostic significance of clinical seizures after cardiac arrest and target temperature management. , 2017, Resuscitation.

[9]  Jonathan Elmer,et al.  Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest , 2016, Annals of neurology.

[10]  D. Brodie,et al.  Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome , 2016, Pharmacotherapy.

[11]  Mary Ann Peberdy,et al.  Part 8: Post–Cardiac Arrest Care 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care , 2015, Circulation.

[12]  N. Nielsen,et al.  Temperature management after cardiac arrest , 2015, Current opinion in critical care.

[13]  Barbara T. Unger,et al.  Neurologic Outcomes and Postresuscitation Care of Patients With Myoclonus Following Cardiac Arrest* , 2015, Critical care medicine.

[14]  D. Seder,et al.  Moderate-Dose Sedation and Analgesia During Targeted Temperature Management After Cardiac Arrest , 2015, Neurocritical Care.

[15]  S. Trzeciak,et al.  Arterial Blood Pressure and Neurologic Outcome After Resuscitation From Cardiac Arrest* , 2014, Critical care medicine.

[16]  Barbara Gold,et al.  Abstract 47: Awakening After Cardiac Arrest and Post-Resuscitation Hypothermia: Are We Pulling the Plug too Early? , 2010 .

[17]  J. Lundbye,et al.  The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. , 2013, Resuscitation.

[18]  R. Jaeschke,et al.  Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit , 2013, Critical care medicine.

[19]  P. Klepstad,et al.  Effects of Hypothermia on the Disposition of Morphine, Midazolam, Fentanyl, and Propofol in Intensive Care Unit Patients , 2013, Drug Metabolism and Disposition.

[20]  S. Mayer,et al.  Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients , 2012, Critical Care.

[21]  Sangeeta Mehta,et al.  Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. , 2012, JAMA.

[22]  S. Jaber,et al.  The Practice of Therapeutic Hypothermia after Cardiac Arrest in France: A National Survey , 2012, PloS one.

[23]  S. Lydersen,et al.  Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial , 2012, Intensive Care Medicine.

[24]  M. Kuiper,et al.  Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. , 2012, American heart journal.

[25]  M. Mlynash,et al.  Sedation Confounds Outcome Prediction in Cardiac Arrest Survivors Treated with Hypothermia , 2011, Neurocritical care.

[26]  K. Weant,et al.  Pharmacologic Options for Reducing the Shivering Response to Therapeutic Hypothermia , 2010, Pharmacotherapy.

[27]  A. Egberts,et al.  Effects of Hypothermia on Pharmacokinetics and Pharmacodynamics , 2010, Clinical pharmacokinetics.

[28]  M. A. Romera,et al.  Anesthesia and Analgesia Protocol During Therapeutic Hypothermia After Cardiac Arrest: A Systematic Review , 2010, Anesthesia and analgesia.

[29]  ownload Demystifyi.  Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing , 2010 .

[30]  J. Parrillo,et al.  Significance of arterial hypotension after resuscitation from cardiac arrest* , 2009, Critical care medicine.

[31]  K. Sunde,et al.  Outcome, timing and adverse events in therapeutic hypothermia after out‐of‐hospital cardiac arrest , 2009, Acta anaesthesiologica Scandinavica.

[32]  Ingeborg H. F. Herold,et al.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods* , 2009, Critical care medicine.

[33]  P. Kochanek,et al.  Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system , 2007, Critical care medicine.

[34]  B. Erstad,et al.  Opioid Conversions in Acute Care , 2007, The Annals of pharmacotherapy.

[35]  C. Gélinas,et al.  Validation of the critical-care pain observation tool in adult patients. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[36]  Sangeeta Mehta,et al.  Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients* , 2006, Critical care medicine.

[37]  A. Hart,et al.  Prediction of poor outcome within the first 3 days of postanoxic coma , 2006, Neurology.

[38]  R. MacLaren,et al.  Pharmacoeconomic Modeling of Lorazepam, Midazolam, and Propofol for Continuous Sedation in Critically Ill Patients , 2005, Pharmacotherapy.

[39]  A. Lupp,et al.  The Effect of Mild Hypothermia on Plasma Fentanyl Concentration and Biotransformation in Juvenile Pigs , 2005, Anesthesia and analgesia.

[40]  F. Cerra,et al.  Pharmacokinetics and pharmacodynamics in critically ill patients , 1987, World Journal of Surgery.

[41]  M. Aibiki,et al.  Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia. , 2004, Resuscitation.

[42]  J. Chiche,et al.  Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. , 2002, Journal of the American College of Cardiology.

[43]  C. Sessler,et al.  The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. , 2002, American journal of respiratory and critical care medicine.

[44]  Philip D Lumb,et al.  Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. , 2002, Critical care medicine.

[45]  G. Knudsen,et al.  Autoregulation of Cerebral Blood Flow in Patients Resuscitated From Cardiac Arrest , 2001, Stroke.

[46]  G. Fraser,et al.  Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. , 1999, Critical care medicine.

[47]  G. Carrasco,et al.  Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. , 1998, Critical care medicine.

[48]  R. Barrientos-Vega,et al.  Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. , 1997, Critical care medicine.